Mammalian sialidases: Physiological and pathological roles in cellular functions

Glycobiology

Volumn 22, Issue 7, 2012, Pages 880-896

  Miyagi, Taeko ^a   Yamaguchi, Kazunori ^b  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer; Ganglioside; Glycoprotein; Sialidase; Sialidosis

Indexed keywords

SIALIDASE; SIALIDASE NEU1; SIALIDASE NEU2; SIALIDASE NEU3; SIALIDASE NEU4; UNCLASSIFIED DRUG;

BINDING SITE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CELL FUNCTION; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME MECHANISM; ENZYME SPECIFICITY; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; LYSOSOME; MAMMAL; MEDICAL RESEARCH; MICROBIAL METABOLISM; MICROORGANISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VERTEBRATE;

AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; GENE COMPONENTS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEURAMINIDASE; NEURITES; REGENERATION; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

MAMMALIA; VERTEBRATA;

EID: 84861413498     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws057     Document Type: Review

References (143)

1. Abdulkhalek S, Amith SR, Franchuk SL, Jayanth P, Guo M, Finlay T, Gilmour A, Guzzo C, Gee K, Beyaert R, et al. 2011. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling. J Biol Chem. 286:36532-36549.
2. Achyuthan KE, Achyuthan AM. 2001. Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases). Comp Biochem Physiol B Biochem Mol Biol. 129:29-64. (Pubitemid 32401124)
3. Akita H, Miyagi T, Hata K, Kagayama M. 1997. Immunohistochemical evidence for the existence of rat cytosolic sialidase in rat skeletal muscles. Histochem Cell Biol. 107:495-503. (Pubitemid 27306979)
4. Albohy A, Li MD, Zheng RB, Zou C, Cairo CW. 2010. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis. Glycobiology. 20:1127-1138.
5. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R, Pshezhetsky AV, Szewczuk MR. 2010. Neu1 desialylation of sialyl α-2,3-linked β-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal. 22:314-324.
6. Anastasia L, Papini N, Colazzo F, Palazzolo G, Tringali C, Dileo L, Piccoli M, Conforti E, Sitzia C, Monti E, et al. 2008. NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis. J Biol Chem. 283:36265-36271.
7. Arabkhari M, Bunda S, Wang Y, Wang A, Pshezhetsky AV, Hinek A. 2010. Desialylation of insulin receptors and IGF-1 receptors by neuraminidase-1 controls the net proliferative response of L6 myoblasts to insulin. Glycobiology. 20:603-616.
8. Aureli M, Loberto N, Lanteri P, Chigorno V, Prinetti A, Sonnino S. 2010. Cell surface sphingolipid glycohydrolases in neuronal differentiation and aging in culture. J Neurochem. 116:891-899.
9. Bigi A, Morosi L, Pozzi C, Forcella M, Tettamanti G, Venerando B, Monti E, Fusi P. 2010. Human sialidase NEU4 long and short are extrinsic proteins bound to outer mitochondrial membrane and the endoplasmic reticulum, respectively. Glycobiology. 20:148-157.
10. Bilyy R, Tomin A, Mahorivska I, Shalay O, Lohinskyy V, Stoika R, Kit Y. 2011. Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma. J Mol Recognit. 24:576-584.
11. Bonten EJ, Campos Y, Zaitsev V, Nourse A, Waddell B, Lewis W, Taylor G, d'Azzo A. 2009. Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization. J Biol Chem. 284:28430-28441.
12. Bonten E, van der Spoel A, Fornerod M, Grosveld G, d'Azzo A. 1996. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 10:3156-3169. (Pubitemid 27020543)
13. Camilli TC, Xu M, O'Connell MP, Chien B, Frank BP, Subaran S, Indig FE, Morin PJ, Hewitt SM, Weeraratna AT. 2010. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res. 24:175-186.
14. Carrillo MB, Milner CM, Ball ST, Snoek M, Campbell RD. 1997. Cloning and characterization of a sialidase from the murine histocompatibility-2 complex: Low levels of mRNA and a single amino acid mutation are responsible for reduced sialidase activity in mice carrying the Neu1a allele. Glycobiology. 7:975-986.
15. Carubelli R, Trucco RE, Caputto R. 1962. Neuraminidase activity in mammalian organs. Biochim Biophys Acta. 60:196-197.
16. Cha SK, Ortega B, Kurosu H, Rosenblatt KP, Kuro OM, Huang CL. 2008. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA. 105:9805-9810. (Pubitemid 352031381)
17. Champigny MJ, Johnson M, Igdoura SA. 2003. Characterization of the mouse lysosomal sialidase promoter. Gene. 319:177-187. (Pubitemid 37346212)
18. Chavas LM, Kato R, Suzuki N, von Itzstein M, Mann MC, Thomson RJ, Dyason JC, McKimm-Breschkin J, Fusi P, Tringali C, et al. 2010. Complexity in influenza virus targeted drug design: Interaction with human sialidases. J Med Chem. 53:2998-3002.
19. Chavas LM, Tringali C, Fusi P, Venerando B, Tettamanti G, Kato R, Monti E, Wakatsuki S. 2005. Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition. J Biol Chem. 280:469-475. (Pubitemid 40165011)
20. Comelli EM, Amado M, Lustig SR, Paulson JC. 2003. Identification and expression of Neu4, a novel murine sialidase. Gene. 321:155-161. (Pubitemid 37421406)
21. Corfield T. 1992. Bacterial sialidases-roles in pathogenicity and nutrition. Glycobiology. 2:509-521.
22. Corfield AP, Michalski JC, Schauer R. 1981. The substrate specificity of sialidase from microorganisms and mammals. In: Tattamanti G, Durand P, Di Donate S, editors. Perspectives in Inherited Metabolic Diseases, Vol. 4. Milan (Italy): Edi Ermes. p. 3-70.
23. Corfield AP, Schauer R. 1982. Metabolism of sialic acid. In: Schauer R, editor. Sialic Acids-Chemistry, Metabolism, and Function. Berlin: Springer-Verlag. p. 195-261.
24. Crennell SJ, Garman EF, Laver WG, Vimr ER, Taylor GL. 1993. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. Proc Natl Acad Sci USA. 90:9852-9856. (Pubitemid 23328208)
25. Cross AS, Sakarya S, Rifat S, Held TK, Drysdale BE, Grange PA, Cassels FJ, Wang LX, Stamatos N, Farese A, et al. 2003. Recruitment of murine neutrophils in vivo through endogenous sialidase activity. J Biol Chem. 278:4112-4120. (Pubitemid 36801147)
26. Da Silva JS, Hasegawa T, Miyagi T, Dotti CG, Abad-Rodriguez J. 2005. Asymmetric membrane ganglioside sialidase activity specifies axonal fate. Nat Neurosci. 8:606-615. (Pubitemid 40594202)
27. d'Azzo A, Bonten E. 2010. Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease. Biochem Soc Trans. 38:1453-1457.
28. D'Azzo A, Hoogeveen A, Reuser AJ, Robinson D, Galjaard H. 1982. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci USA. 79:4535-4539.
29. Fanzani A, Colombo F, Giuliani R, Preti A, Marchesini S. 2004. Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. FEBS Lett. 566:178-182. (Pubitemid 38625955)
30. Fanzani A, Giuliani R, Colombo F, Zizioli D, Presta M, Preti A, Marchesini S. 2003. Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. FEBS Lett. 547:183-188. (Pubitemid 36829402)
31. Feng C, Zhang L, Almulki L, Faez S, Whitford M, Hafezi-Moghadam A, Cross AS. 2011. Endogenous PMN sialidase activity exposes activation epitope on CD11b/CD18 which enhances its binding interaction with ICAM-1. J Leukoc Biol. 90:313-321.
32. Ferrari J, Harris R, Warner TG. 1994. Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: Sequence alignment similarities to bacterial sialidases. Glycobiology. 4:367-373. (Pubitemid 24217253)
33. Finlay TM, Abdulkhalek S, Gilmour A, Guzzo C, Jayanth P, Amith SR, Gee K, Beyaert R, Szewczuk MR. 2010. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo. Glycoconj J. 27:583-600.
34. Fronda CL, Zeng G, Gao L, Yu RK. 1999. Molecular cloning and expression of mouse brain sialidase. Biochem Biophys Res Commun. 258:727-731. (Pubitemid 29290337)
35. Funakoshi Y, Suzuki T. 2009. Glycobiology in the cytosol: The bitter side of a sweet world. Biochim Biophys Acta. 1790:81-94.
36. Galjart NJ, Gillemans N, Harris A, van der Horst GT, Verheijen FW, Galjaard H, d'Azzo A. 1988. Expression of cDNA encoding the human "protective protein" associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases. Cell. 54:755-764.
37. Hasegawa T, Sugeno N, Takeda A, Matsuzaki-Kobayashi M, Kikuchi A, Furukawa K, Miyagi T, Itoyama Y. 2007. Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites. FEBS Lett. 581:406-412. (Pubitemid 46149610)
38. Hasegawa T, Yamaguchi K, Wada T, Takeda A, Itoyama Y, Miyagi T. 2000. Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J Biol Chem. 275:8007-8015. (Pubitemid 30159712)
39. Hata K, Koseki K, Yamaguchi K, Moriya S, Suzuki Y, Yingsakmongkon S, Hirai G, Sodeoka M, von Itzstein M, Miyagi T. 2008. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother. 52:3484-3491.
40. Hata K, Wada T, Hasegawa A, Kiso M, Miyagi T. 1998. Purification and characterization of a membrane-associated ganglioside sialidase from bovine brain. J Biochem (Tokyo). 123:899-905. (Pubitemid 28226987)
41. Hinek A, Bodnaruk TD, Bunda S, Wang Y, Liu K. 2008. Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2. Am J Pathol. 173:1042-1056.
42. Hinek A, Pshezhetsky AV, von Itzstein M, Starcher B. 2006. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J Biol Chem. 281:3698-3710. (Pubitemid 43845988)
43. Igdoura SA, Gafuik C, Mertineit C, Saberi F, Pshezhetsky AV, Potier M, Trasler JM, Gravel RA. 1998. Cloning of the cDNA and gene encoding mouse lysosomal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts. Hum Mol Genet. 7:115-121.
44. Ishizuka A, Hashimto Y, Naka R, Kinoshita M, Kakehi K, Seino J, Funakoshi Y, Suzuki T, Kameyama A, Narimatsu H. 2008. Accumulation of free complex-type N-glycans in MKN7 and MKN45 stomach cancer cells. Biochem J. 413:227-237.
45. Jayanth P, Amith SR, Gee K, Szewczuk MR. 2010. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling. Cell Signal. 22:1193-1205.
46. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T. 2002. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA. 99:10718-10723.
47. Kalka D, von Reitzenstein C, Kopitz J, Cantz M. 2001. The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts. Biochem Biophys Res Commun. 283:989-993. (Pubitemid 32924678)
48. Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K, Saijo S, Miyagi T. 2006. Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin-and fibronectin-derived signalling. Biochem J. 394:647-656.
49. Kato T, Wang Y, Yamaguchi K, Milner CM, Shineha R, Satomi S, Miyagi T. 2001. Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells. Int J Cancer. 92:797-804. (Pubitemid 32467367)
50. Katoh S, Maeda S, Fukuoka H, Wada T, Moriya S, Mori A, Yamaguchi K, Senda S, Miyagi T. 2010. A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model. Clin Exp Immunol. 161:233-241.
51. Katoh S, Miyagi T, Taniguchi H, Matsubara Y, Kadota J, Tominaga A, Kincade PW, Matsukura S, Kohno S. 1999. Cutting edge: An inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol. 162:5058-5061. (Pubitemid 29307104)
52. Kawamura S, Sato I, Wada T, Yamaguchi K, Li Y, Li D, Zhao X, Ueno S, Aoki H, Tochigi T, et al. 2012. Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling. Cell Death Differ. 19:170-179.
53. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, et al. 2006. Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 16:55-65. (Pubitemid 43048934)
54. Kishore CS, Tulsiani DR, Bhavanandan VP, Carubelli R. 1975. Membranebound neuraminidases of rat liver. Neuraminidase activity in Golgi apparatus. J Biol Chem. 250:2655-2659.
55. Kopitz J, Oehler C, Cantz M. 2001. Desialylation of extracellular GD1a-neoganglioprotein suggests cell surface orientation of the plasma membrane-bound ganglioside sialidase activity in human neuroblastoma cells. FEBS Lett. 491:233-236. (Pubitemid 32193802)
56. Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius HJ. 1998. Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem. 273:11205-11211. (Pubitemid 28204971)
57. Kopitz J, von Reitzenstein C, Muhl C, Cantz M. 1994. Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation. Biochem Biophys Res Commun. 199:1188-1193. (Pubitemid 24174784)
58. Kotani K, Kuroiwa A, Saito T, Matsuda Y, Koda T, Kijimoto-Ochiai S. 2001. Cloning, chromosomal mapping, and characteristic 5′-UTR sequence of murine cytosolic sialidase. Biochem Biophys Res Commun. 286:250-258. (Pubitemid 32926753)
59. Kuro-o M. 2009. Klotho and aging. Biochim Biophys Acta. 1790:1049-1058.
60. Li SC, Li YT, Moriya S, Miyagi T. 2001. Degradation of G(M1) and G(M2) by mammalian sialidases. Biochem J. 360:233-237. (Pubitemid 33081969)
61. Li X, Zhang L, Shao Y, Liang Z, Shao C, Wang B, Guo B, Li N, Zhao X, Li Y, et al. 2011. Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion. Biochem Biophys Res Commun. 416:270-276.
62. Liang F, Seyrantepe V, Landry K, Ahmad R, Ahmad A, Stamatos NM, Pshezhetsky AV. 2006. Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments. J Biol Chem. 281:27526-27538. (Pubitemid 44401779)
63. Lukong KE, Seyrantepe V, Landry K, Trudel S, Ahmad A, Gahl WA, Lefrancois S, Morales CR, Pshezhetsky AV. 2001. Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J Biol Chem. 276:46172-46181.
64. Magesh S, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M. 2008. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1). Bioorg Med Chem Lett. 18:532-537.
65. Mahadevan S, Nduaguba JC, Tappel AL. 1967. Sialidase of rat liver and kidney. J Biol Chem. 242:4409-4413.
66. Malisan F, Testi R. 2002. GD3 ganglioside and apoptosis. Biochim Biophys Acta. 1585:179-187. (Pubitemid 36092083)
67. Mandal C, Tringali C, Mondal S, Anastasia L, Chandra S, Venerando B. 2010. Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells. Int J Cancer. 126:337-349.
68. Meuillet EJ, Kroes R, Yamamoto H, Warner TG, Ferrari J, Mania-Farnell B, George D, Rebbaa A, Moskal JR, Bremer EG. 1999. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431. Cancer Res. 59:234-240. (Pubitemid 29062983)
69. Milner CM, Smith SV, Carrillo MB, Taylor GL, Hollinshead M, Campbell RD. 1997. Identification of a sialidase encoded in the human major histocompatibility complex. J Biol Chem. 272:4549-4558. (Pubitemid 27078536)
70. Minami A, Shimizu H, Meguro Y, Shibata N, Kanazawa H, Ikeda K, Suzuki T. 2011. Imaging of sialidase activity in rat brain sections by a highly sensitive fluorescent histochemical method. Neuroimage. 58:34-40.
71. Miyagi T. 2008. Aberrant expression of sialidase and cancer progression. Proc Jpn Acad Ser B Phys Biol Sci. 84:407-418.
72. Miyagi T, Konno K, Emori Y, Kawasaki H, Suzuki K, Yasui A, Tsuik S. 1993. Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. J Biol Chem. 268:26435-26440. (Pubitemid 23361720)
73. Miyagi T, Sagawa J, Konno K, Handa S, Tsuiki S. 1990. Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain. J Biochem (Tokyo). 107:787-793. (Pubitemid 20173328)
74. Miyagi T, Sato K, Hata K, Taniguchi S. 1994. Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity. FEBS Lett. 349:255-259. (Pubitemid 24263273)
75. Miyagi T, Tsuiki S. 1984. Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase. Eur J Biochem. 141:75-81. (Pubitemid 14106264)
76. Miyagi T, Tsuiki S. 1985. Purification and characterization of cytosolic sialidase from rat liver. J Biol Chem. 260:6710-6716. (Pubitemid 15005857)
77. Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, Sawada M. 1999. Molecular cloning and characterization of a plasma membraneassociated sialidase specific for gangliosides. J Biol Chem. 274:5004-5011.
78. Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K. 2008. Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling. J Biochem. 144:279-285.
79. Miyagi T, Yamaguchi K. 2007. Sialic acids. In: Kamerling JP, Boons G-J, Lee YC, Suzuki A, Taniguchi N, Voragen AGJ, editors. Comprehensive Glycoscience, Vol. 3. Oxford: Elsevier Ltd. p. 297-323.
80. Monti E, Bassi MT, Bresciani R, Civini S, Croci GL, Papini N, Riboni M, Zanchetti G, Ballabio A, Preti A, et al. 2004. Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family. Genomics. 83:445-453. (Pubitemid 38220849)
81. Monti E, Bassi MT, Papini N, Riboni M, Manzoni M, Venerando B, Croci G, Preti A, Ballabio A, Tettamanti G, et al. 2000. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem J. 349:343-351. (Pubitemid 30440200)
82. Monti E, Bonten E, D'Azzo A, Bresciani R, Venerando B, Borsani G, Schauer R, Tettamanti G. 2010. Sialidases in vertebrates: A family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem. 64:403-479.
83. Monti E, Preti A, Rossi E, Ballabio A, Borsani G. 1999. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics. 57:137-143. (Pubitemid 29187946)
84. Monti E, Preti A, Venerando B, Borsani G. 2002. Recent development in mammalian sialidase molecular biology. Neurochem Res. 27:649-663.
85. Moon SK, Cho SH, Kim KW, Jeon JH, Ko JH, Kim BY, Kim CH. 2007. Overexpression of membrane sialic acid-specific sialidase Neu3 inhibits matrix metalloproteinase-9 expression in vascular smooth muscle cells. Biochem Biophys Res Commun. 356:542-547. (Pubitemid 46499001)
86. Mountney A, Zahner MR, Lorenzini I, Oudega M, Schramm LP, Schnaar RL. 2010. Sialidase enhances recovery from spinal cord contusion injury. Proc Natl Acad Sci USA. 107:11561-11566.
87. Nan X, Carubelli I, Stamatos NM. 2007. Sialidase expression in activated human T lymphocytes influences production of IFN-γ. J Leukoc Biol. 81:284-296. (Pubitemid 46021278)
88. Ohashi S, Iwai K, Mega T, Hase S. 1999. Quantitation and isomeric structure analysis of free oligosaccharides present in the cytosol fraction of mouse liver: Detection of a free disialobiantennary oligosaccharide and glucosylated oligomannosides. J Biochem. 126:852-858.
89. Papini N, Anastasia L, Tringali C, Croci G, Bresciani R, Yamaguchi K, Miyagi T, Preti A, Prinetti A, Prioni S, et al. 2004. The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem. 279:16989-16995. (Pubitemid 38560452)
90. Proshin S, Yamaguchi K, Wada T, Miyagi T. 2002. Modulation of neuritogenesis by ganglioside-specific sialidase (Neu 3) in human neuroblastoma NB-1 cells. Neurochem Res. 27:841-846.
91. Pshezhetsky AV, Hinek A. 2011. Where catabolism meets signalling: Neuraminidase 1 as a modulator of cell receptors. Glycoconj J. 28:441-452.
92. Pshezhetsky AV, Richard C, Michaud L, Igdoura S, Wang S, Elsliger MA, Qu J, Leclerc D, Gravel R, Dallaire L, et al. 1997. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet. 15:316-320. (Pubitemid 27098731)
93. Rodriguez JA, Piddini E, Hasegawa T, Miyagi T, Dotti CG. 2001. Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture. J Neurosci. 21:8387-8395. (Pubitemid 33051437)
94. Roggentin P, Schauer R, Hoyer LL, Vimr ER. 1993. The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol. 9:915-921. (Pubitemid 23271769)
95. Rosenberg A, Schengrund CL. 1976. Sialidases. In: Rosenberg A, Schengrund CL, editors. Biological Roles of Sialic Acid. New York: Plenum Press. p. 295-359.
96. Rottier RJ, Bonten E, d'Azzo A. 1998. A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse. Hum Mol Genet. 7:313-321. (Pubitemid 28048548)
97. Saito M, Fronda CL, Yu RK. 1996. Sialidase activity in nuclear membranes of rat brain. J Neurochem. 66:2205-2208. (Pubitemid 26118816)
98. Saito M, Yu RK. 1995. Biochemistry and function of sialidases. In: Rosenberg A, editor. Biology of the Sialic Acids. New York: Plenum Press. p. 261-313.
99. Sandbhor MS, Soya N, Albohy A, Zheng RB, Cartmell J, Bundle DR, Klassen JS, Cairo CW. 2011. Substrate recognition of the membraneassociated sialidase NEU3 requires a hydrophobic aglycone. Biochemistry. 50:6753-6762.
100. Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J, Forte M, d'Azzo A. 2009. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca2+dependent mitochondrial apoptosis. Mol Cell. 36:500-511.
101. Sasaki A, Hata K, Suzuki S, Sawada M, Wada T, Yamaguchi K, Obinata M, Tateno H, Suzuki H, Miyagi T. 2003. Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice. J Biol Chem. 278:27896-27902. (Pubitemid 36899982)
102. Sato K, Miyagi T. 1995. Genomic organization and the 5′-upstream sequence of the rat cytosolic sialidase gene. Glycobiology. 5:511-516.
103. Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T, Tsuruo T, Kannagi R, Miyagi T. 2002. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer. 97:180-185. (Pubitemid 34019953)
104. Schengrund C-L, Rosenberg A. 1970. Intracellular location and properties of bovine brain sialidase. J Biol Chem. 245:6196-6200.
105. Seyrantepe V, Canuel M, Carpentier S, Landry K, Durand S, Liang F, Zeng J, Caqueret A, Gravel RA, Marchesini S, et al. 2008. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage. Hum Mol Genet. 17:1556-1568. (Pubitemid 351737160)
106. Seyrantepe V, Hinek A, Peng J, Fedjaev M, Ernest S, Kadota Y, Canuel M, Itoh K, Morales CR, Lavoie J, et al. 2008. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation. 117:1973-1981. (Pubitemid 351543473)
107. Seyrantepe V, Iannello A, Liang F, Kanshin E, Jayanth P, Samarani S, Szewczuk MR, Ahmad A, Pshezhetsky AV. 2010. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem. 285:206-215.
108. Seyrantepe V, Landry K, Trudel S, Hassan JA, Morales CR, Pshezhetsky AV. 2004. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells. J Biol Chem. 279:37021-37029. (Pubitemid 39129052)
109. Seyrantepe V, Lema P, Caqueret A, Dridi L, Bel Hadj S, Carpentier S, Boucher F, Levade T, Carmant L, Gravel RA, et al. 2010. Mice doublydeficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss. PLoS Genet. 6: e1001118.
110. Seyrantepe V, Poupetova H, Froissart R, Zabot MT, Maire I, Pshezhetsky AV. 2003. Molecular pathology of NEU1 gene in sialidosis. Hum Mutat. 22:343-352. (Pubitemid 37346106)
111. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. 2011. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate. 71:538-549.
112. Shiozaki K, Koseki K, Yamaguchi K, Shiozaki M, Narimatsu H, Miyagi T. 2009. Developmental change of sialidase neu4 expression in murine brain and its involvement in the regulation of neuronal cell differentiation. J Biol Chem. 284:21157-21164.
113. Shiozaki K, Yamaguchi K, Sato I, Miyagi T. 2009. Plasma membraneassociated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice. Cancer Sci. 100:588-594.
114. Shiozaki K, Yamaguchi K, Takahashi K, Moriya S, Miyagi T. 2011. Regulation of sialyl Lewis antigen expression in colon cancer cells by sialidase NEU4. J Biol Chem. 286:21052-21061.
115. Sorice M, Matarrese P, Tinari A, Giammarioli AM, Garofalo T, Manganelli V, Ciarlo L, Gambardella L, Maccari G, Botta M, et al. 2009. Raft component GD3 associates with tubulin following CD95/Fas ligation. FASEB J. 23:3298-3308.
116. Stamatos NM, Carubelli I, van de Vlekkert D, Bonten EJ, Papini N, Feng C, Venerando B, d'Azzo A, Cross AS, Wang LX, et al. 2010. LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity. J Leukoc Biol. 88:1227-1239.
117. Stamatos NM, Liang F, Nan X, Landry K, Cross AS, Wang LX, Pshezhetsky AV. 2005. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. FEBS J. 272:2545-2556. (Pubitemid 40705074)
118. Stoppani E, Rossi S, Marchesini S, Preti A, Fanzani A. 2009. Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. Cell Biol Int. 33:1020-1025.
119. Suzuki N, Aoki M, Hinuma Y, Takahashi T, Onodera Y, Ishigaki A, Kato M, Warita H, Tateyama M, Itoyama Y. 2005. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL). Neurosci Res. 52:47-60. (Pubitemid 40461871)
120. Tokuyama S, Moriya S, Taniguchi S, Yasui A, Miyazaki J, Orikasa S, Miyagi T. 1997. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int J Cancer. 73:410-415. (Pubitemid 27508904)
121. Tringali C, Lupo B, Anastasia L, Papini N, Monti E, Bresciani R, Tettamanti G, Venerando B. 2007. Expression of sialidase Neu2 in leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signaling. J Biol Chem. 282:14364-14372. (Pubitemid 47100478)
122. Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, Sakuraba H, Miyagi T. 2009. Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene. 28:1218-1229.
123. Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, Arai Y, Miyagi T. 2006. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem. 281:7756-7764. (Pubitemid 43847389)
124. Valaperta R, Chigorno V, Basso L, Prinetti A, Bresciani R, Preti A, Miyagi T, Sonnino S. 2006. Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J. 20:1227-1229.
125. Veracini L, Simon V, Richard V, Schraven B, Horejsi V, Roche S, Benistant C. 2008. The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1. J Cell Biol. 182:603-614.
126. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T. 2007. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene. 26:2483-2490. (Pubitemid 46597274)
127. Wada T, Yoshikawa Y, Tokuyama S, Kuwabara M, Akita H, Miyagi T. 1999. Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun. 261:21-27. (Pubitemid 29371612)
128. Wang XQ, Sun P, Paller AS. 2002. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem. 277:47028-47034. (Pubitemid 36159210)
129. Wang J, Wu G, Miyagi T, Lu ZH, Ledeen RW. 2009. Sialidase occurs in both membranes of the nuclear envelope and hydrolyzes endogenous GD1a. J Neurochem. 111:547-554.
130. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T, Miyagi T. 2002. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem. 277:26252-26259. (Pubitemid 34967114)
131. Wang D, Zaitsev S, Taylor G, d'Azzo A, Bonten E. 2009. Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1. Biochim Biophys Acta. 1790:275-282.
132. Warren L, Spearing CW. 1960. Mammalian sialidase (neuraminidase). Biochem Biophys Res Commun. 3:489-492.
133. Wierstra I. 2008. Sp1:emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun. 372:1-13.
134. Wu X, Steigelman KA, Bonten E, Hu H, He W, Ren T, Zuo J, d'Azzo A. 2010. Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. Biochim Biophys Acta. 1802:259-268.
135. Yamaguchi K, Hata K, Koseki K, Shiozaki K, Akita H, Wada T, Moriya S, Miyagi T. 2005. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J. 390:85-93. (Pubitemid 41192234)
136. Yamaguchi K, Hata K, Wada T, Moriya S, Miyagi T. 2006. Epidermal growth factor-induced mobilization of a ganglioside-specific sialidase (NEU3) to membrane ruffles. Biochem Biophys Res Commun. 346:484-490. (Pubitemid 43902710)
137. Yamaguchi K, Koseki K, Shiozaki M, Shimada Y, Wada T, Miyagi T. 2010. Regulation of plasma-membrane-associated sialidase NEU3 gene by Sp1/Sp3 transcription factors. Biochem J. 430:107-117.
138. Yamanami H, Shiozaki K, Wada T, Yamaguchi K, Uemura T, Kakugawa Y, Hujiya T, Miyagi T. 2007. Down-regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers. Cancer Sci. 98:299-307. (Pubitemid 46195598)
139. Yang LJ, Lorenzini I, Vajn K, Mountney A, Schramm LP, Schnaar RL. 2006. Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci USA. 103:11057-11062. (Pubitemid 44148417)
140. Yogalingam G, Bonten EJ, van de Vlekkert D, Hu H, Moshiach S, Connell SA, d'Azzo A. 2008. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell. 15:74-86. (Pubitemid 351895600)
141. Zanchetti G, Colombi P, Manzoni M, Anastasia L, Caimi L, Borsani G, Venerando B, Tettamanti G, Preti A, Monti E, et al. 2007. Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures. Biochem J. 408:211-219. (Pubitemid 350206344)
142. Zanoteli E, van de Vlekkert D, Bonten EJ, Hu H, Mann L, Gomero EM, Harris AJ, Ghersi G, d'Azzo A. 2010. Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue. Biochim Biophys Acta. 1802:659-672.
143. Zou Y, Albohy A, Sandbhor M, Cairo CW. 2010. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-Nacetyl- neuraminic acid. Bioorg Med Chem Lett. 20:7529-7533.